Kaliumjodide Serb

Potassium Iodide, the active ingredient in Kaliumjodide Serb, is an iodide (thyroid blocking agent) presented as an oral preparation for oral use. It is employed to protect the thyroid gland by limiting the uptake of radioactive iodine during radiation emergencies and certain nuclear medicine procedures.

GNH USA supplies Kaliumjodide Serb as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Kaliumjodide Serb acts on the thyroid gland to block iodine uptake in situations involving radioactive iodine exposure. - Radiation emergency: reduces thyroid absorption of radioactive iodine, decreasing radiation dose to the gland. - Radioiodine therapy: provides temporary thyroid blockade to protect normal tissue during diagnostic or therapeutic iodine‑131 procedures. - Iodine deficiency prophylaxis: supplies supplemental iodide to prevent deficiency in populations at risk.

Oral administration of potassium iodide may be associated with several adverse reactions, ranging from mild to severe.

Common Side Effects: - Taste alteration: a metallic or salty taste in the mouth. - Gastrointestinal discomfort: nausea, vomiting, or abdominal cramps. - Mild skin rash: localized erythema or itching. - Sialadenitis: swelling of the salivary glands.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction with respiratory distress. - Thyrotoxicosis: excessive thyroid hormone production in susceptible individuals. - Hypothyroidism: reduced thyroid function following prolonged exposure.

Before using Kaliumjodide Serb, consider the following precautions to ensure safe administration. - Pregnancy: consult a healthcare professional as safety data are limited. - Breastfeeding: discuss potential risks with a physician before use. - Pre‑existing thyroid disease: monitor thyroid function tests closely. - Known hypersensitivity: avoid if allergic to potassium iodide or excipients. - Concomitant medications: review all drugs with a clinician to identify possible interactions. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Potassium iodide can interact with several medicines; awareness of these interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Lithium: may exacerbate lithium‑induced thyroid dysfunction. - Amiodarone: combined iodine load can increase risk of thyroid abnormalities. - Antithyroid drugs (e.g., methimazole): may diminish the intended thyroid‑blocking effect.

Moderate Interactions (Monitor Closely): - ACE inhibitors: potential alteration of potassium balance. - Loop diuretics: may affect renal excretion of iodide. - Radioactive iodine therapy: timing should be coordinated to avoid reduced efficacy.